Searched for: in-biosketch:true
person:fingep01
Topical mitomycin chemotherapy (TMC) for conjunctival malignant melanoma and primary acquired melanosis with atypia: A 10-year study [Meeting Abstract]
Kurli, M; Finger, PT
ISI:000227980406169
ISSN: 0146-0404
CID: 104511
The finger iridectomy technique (FIT): Minimally invasive iris biopsy, iridectomy and tumor excision [Meeting Abstract]
Finger, PT
ISI:000227980405709
ISSN: 0146-0404
CID: 104510
Finding malignant change in a necrotic choroidal melanocytoma: a clinical challenge [Letter]
Kurli, M; Finger, P T; Manor, T; McCormick, S A; Grossniklaus, H E
PMCID:1772711
PMID: 15965181
ISSN: 0007-1161
CID: 129367
The Finger iridectomy technique: small incision biopsy of anterior segment tumours
Finger, P T; Latkany, P; Kurli, M; Iacob, C
AIMS: To develop a minimally invasive, maximally effective method to biopsy anterior segment tumours. METHODS: A 25 gauge aspiration cutter (vitrector) was used to biopsy anterior segment tumours. The probe was introduced under sodium hyaluronate 1% and through a 1 mm incision. Aspiration (600 mm Hg) cutting (300 cpm) was performed to obtain specimens for cytology and histopathology. RESULTS: Diagnostic material was obtained in nine of 10 (90%) cases. Diagnoses included iris naevus, iris stroma, malignant melanoma, melanocytoma, epithelial inclusion cyst, and sarcoid granuloma. All corneal wounds were self sealing. One patient developed a transient postoperative increase in intraocular pressure. Within the follow up of this study, no patients suffered intraocular haemorrhage, infection, cataract or vision loss. CONCLUSION: The Finger iridectomy technique was a minimally invasive and very effective biopsy technique. Aspiration cutting yielded relatively large pieces of tissue (and cells) used for cytopathological and histopathological evaluation. Small incision surgery allowed for rapid rehabilitation and no significant complications
PMCID:1772780
PMID: 16024840
ISSN: 0007-1161
CID: 140023
Retinoblastoma in a child conceived by in vitro fertilisation [Letter]
Lee, I; Finger, P T; Grifo, J A; Rausen, A R; Rebarber, A; Barad, D H
PMCID:1772288
PMID: 15258037
ISSN: 0007-1161
CID: 44951
Palladium 103 (103Pd) plaque radiation therapy for circumscribed choroidal hemangioma with retinal detachment
Aizman, Alexander; Finger, Paul T; Shabto, Uri; Szechter, Andrzej; Berson, Anthony
OBJECTIVE: To describe clinical experience with palladium 103 ((103)Pd) ophthalmic plaque radiotherapy for choroidal hemangioma. METHODS: One course of (103)Pd ophthalmic plaque radiotherapy was used in each of 5 patients with circumscribed choroidal hemangioma who had progressive loss of vision due to subretinal exudation. A mean apex dose of 2900 cGy (2900 rad) was delivered. Functional tests of outcome included best-corrected visual acuity. Anatomic results included changes in tumor height and subretinal fluid documented by ophthalmoscopy, fluorescein angiography, and ultrasonography. RESULTS: All patients had complete resolution of subretinal fluid with reattachment of the retina. All tumors decreased in height (mean, 50%) after treatment. Three patients (60%) demonstrated improvement in visual acuity at the last follow-up, and in 1 patient vision remained stable with resolution of metamorphopsia. Twenty-four months after treatment, 1 patient whose visual acuity had recovered from 20/160 to 20/32 had a loss of vision to 20/160 because of radiation maculopathy. For all patients, a mean visual acuity improvement of 2 lines was documented (95% confidence interval, 0.23-0.88). Mean follow-up was 18.6 months (range, 6-29 months). CONCLUSIONS: A single (103)Pd plaque radiation treatment was effective in decreasing tumor height, eliminating subretinal fluid, and improving visual acuity in patients with symptomatic circumscribed choroidal hemangiomas
PMID: 15534126
ISSN: 0003-9950
CID: 47825
Whole body PET/CT imaging for detection of metastatic choroidal melanoma [Letter]
Finger, P T; Kurli, M; Wesley, P; Tena, L; Kerr, K R; Pavlick, A
PMCID:1772278
PMID: 15258035
ISSN: 0007-1161
CID: 44833
Radiation-blocking glasses allow vision during ophthalmic plaque radiation therapy
Finger, Paul T; Szechter, Andrzej
PURPOSE: To evaluate the use of leaded safety glasses to block radiation and allow for vision during ophthalmic plaque radiation therapy. DESIGN: Interventional case series. METHODS: Eight patients were treated with palladium 103 ophthalmic plaque radiotherapy and measured for emitted radiation while wearing leaded glasses or a lead patch. Radiation emission was measured at 1 m so as to compare the glasses' ability to block radiation in vivo. RESULTS: In two patients the tumor was in the patients' only seeing eye, and the leaded radiation safety glasses allowed them to function (feed themselves and walk to the bathroom unassisted). In two additional patients, the glasses allowed binocularity and were preferred over the patch. Measurements revealed that both the lead patch and leaded radiation safety glasses reduced exposure to levels acceptable for discharge to home in New York City. CONCLUSIONS: Leaded radiation safety glasses improved patients' quality of life without sacrificing radiation safety
PMID: 15183814
ISSN: 0002-9394
CID: 46178
Laser photocoagulation to prevent radiation maculopathy after plaque therapy for posterior choroidal melanoma [Meeting Abstract]
Finger PT; Kurli M
ISI:000223338202376
ISSN: 0146-0404
CID: 48936
Regression of uveal melanomas after palladium-103 (Pd-103) plaque brachytherapy [Meeting Abstract]
Chin K; Finger PT; Yu G; Kurli M
ISI:000223338202377
ISSN: 0146-0404
CID: 130288